Rene Nunez Selected Research

Major Depressive Disorder (Major Depressive Disorders)

12/2016	Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
11/2015	Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
7/2015	Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
6/2015	A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.
3/2015	Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
3/2015	Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial.
11/2014	Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
1/2014	Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rene Nunez Research Topics

Disease

8	Major Depressive Disorder (Major Depressive Disorders) 12/2016 - 01/2014
5	Nausea 12/2016 - 01/2014
4	Diarrhea 12/2016 - 11/2014
3	Anxiety Disorders (Anxiety Disorder) 12/2016 - 06/2015
3	Dizziness (Lightheadedness) 12/2016 - 01/2014
2	Erectile Dysfunction 12/2016 - 01/2014
2	Fatigue 12/2016 - 06/2015
2	Vomiting 06/2015 - 03/2015
1	Movement Disorders (Movement Disorder) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Ejaculatory Dysfunction 12/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2015
1	Constipation 01/2014
1	Hyperhidrosis 01/2014

Drug/Important Bio-Agent (IBA)

7	Vilazodone HydrochlorideIBA 12/2016 - 11/2014
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2016 - 03/2015
3	5-HT1A Serotonin ReceptorIBA 12/2016 - 06/2015
1	pimavanserinIBA 01/2020
1	Citalopram FDA LinkGeneric 07/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2014
1	LevomilnacipranIBA 01/2014